Ex vivo and in vitro effect of serum amyloid a in the induction of macrophage M2 markers and efferocytosis of apoptotic neutrophils

Journal of Immunology

Volumn 194, Issue 10, 2015, Pages 4891-4900

  Sun, Lei ^a   Zhou, Huibin ^a   Zhu, Ziyan ^a   Yan, Qian ^a   Wang, Lili ^a   Liang, Qing ^a   Ye, Richard D ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; ARGINASE 1; CELL PROTEIN; FIZZ 1 PROTEIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 23P19; MRC1 PROTEIN; MYELOID DIFFERENTIATION FACTOR 88; RAC1 PROTEIN; SERUM AMYLOID A; SMALL INTERFERING RNA; STAT6 PROTEIN; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; YM1 PROTEIN;

ACTIN POLYMERIZATION; ANIMAL CELL; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL ISOLATION; CHROMATIN IMMUNOPRECIPITATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DNA BINDING; EFFEROCYTOSIS; ENZYME ACTIVITY; EX VIVO STUDY; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; MACROPHAGE; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PERITONEAL CAVITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; C57BL MOUSE; IMMUNOLOGY; KNOCKOUT MOUSE; MACROPHAGE ACTIVATION; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; APOPTOSIS; CHROMATIN IMMUNOPRECIPITATION; HUMANS; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, CONFOCAL; NEUTROPHILS; REAL-TIME POLYMERASE CHAIN REACTION; SERUM AMYLOID A PROTEIN; SIGNAL TRANSDUCTION;

EID: 84929095853     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402164     Document Type: Article

References (50)

1. Gordon, S. 2003. Alternative activation of macrophages. Nat. Rev. Immunol. 3: 23-35.
2. Martinez, F. O., A. Sica, A. Mantovani, and M. Locati. 2008. Macrophage activation and polarization. Front. Biosci. 13: 453-461.
3. Martinez, F. O., S. Gordon, M. Locati, and A. Mantovani. 2006. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J. Immunol. 177: 7303-7311.
4. Mosser, D. M., and J. P. Edwards. 2008. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8: 958-969.
5. Benoit, M., B. Desnues, and J. L. Mege. 2008. Macrophage polarization in bacterial infections. J. Immunol. 181: 3733-3739.
6. Raes, G., R. Van den Bergh, P. De Baetselier, G. H. Ghassabeh, C. Scotton, M. Locati, A. Mantovani, and S. Sozzani. 2005. Arginase-1 and Ym1 are markers for murine, but not human, alternatively activated myeloid cells. J. Immunol. 174: 6561-, author reply 6561-6562.
7. Mantovani, A., A. Sica, S. Sozzani, P. Allavena, A. Vecchi, and M. Locati. 2004. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25: 677-686.
8. Mantovani, A., S. K. Biswas, M. R. Galdiero, A. Sica, and M. Locati. 2013. Macrophage plasticity and polarization in tissue repair and remodelling. J. Pathol. 229: 176-185.
9. Nathan, C. 2006. Neutrophils and immunity: challenges and opportunities. Nat. Rev. Immunol. 6: 173-182.
10. Henson, P. M., D. L. Bratton, and V. A. Fadok. 2001. Apoptotic cell removal. Curr. Biol. 11: R795-R805.
11. Kennedy, A. D., and F. R. DeLeo. 2009. Neutrophil apoptosis and the resolution of infection. Immunol. Res. 43: 25-61.
12. Gordy, C., H. Pua, G. D. Sempowski, and Y. W. He. 2011. Regulation of steady-state neutrophil homeostasis by macrophages. Blood 117: 618-629.
13. Bystrom, J., I. Evans, J. Newson, M. Stables, I. Toor, N. van Rooijen, M. Crawford, P. Colville-Nash, S. Farrow, and D. W. Gilroy. 2008. Resolutionphase macrophages possess a unique inflammatory phenotype that is controlled by cAMP. Blood 112: 4117-4127.
14. Fernandez-Boyanapalli, R., S. C. Frasch, D. W. Riches, R. W. Vandivier, P. M. Henson, and D. L. Bratton. 2010. PPARγ activation normalizes resolution of acute sterile inflammation in murine chronic granulomatous disease. Blood 116: 4512-4522.
15. Schif-Zuck, S., N. Gross, S. Assi, R. Rostoker, C. N. Serhan, and A. Ariel. 2011. Saturated-efferocytosis generates pro-resolving CD11b low macrophages: modulation by resolvins and glucocorticoids. Eur. J. Immunol. 41: 366-379.
16. Kushner, I., and D. Rzewnicki. 1999. Acute phase response. In Inflammation: Basic principles and clinical correlates, 3rd Ed. J. I. Gallin, and R. Snyderman, eds. Lippincott Willams & Wilkins, Philadelphia, p. 317-329.
17. Gabay, C., and I. Kushner. 1999. Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 340: 448-454.
18. Jensen, L. E., and A. S. Whitehead. 1998. Regulation of serum amyloid A protein expression during the acute-phase response. Biochem. J. 334: 489-503.
19. O'Hara, R., E. P. Murphy, A. S. Whitehead, O. FitzGerald, and B. Bresnihan. 2000. Acute-phase serum amyloid A production by rheumatoid arthritis synovial tissue. Arthritis Res. 2: 142-144.
20. Fyfe, A. I., L. S. Rothenberg, F. C. DeBeer, R. M. Cantor, J. I. Rotter, and A. J. Lusis. 1997. Association between serum amyloid A proteins and coronary artery disease: evidence from two distinct arteriosclerotic processes. Circulation 96: 2914-2919.
21. De Beer, F. C., R. K. Mallya, E. A. Fagan, J. G. Lanham, G. R. Hughes, and M. B. Pepys. 1982. Serum amyloid-A protein concentration in inflammatory diseases and its relationship to the incidence of reactive systemic amyloidosis. Lancet 2: 231-234.
22. Kumon, Y., T. Suehiro, T. Itahara, Y. Ikeda, and K. Hashimoto. 1994. Serum amyloid A protein in patients with non-insulin-dependent diabetes mellitus. Clin. Biochem. 27: 469-473.
23. Badolato, R., J. M. Wang, W. J. Murphy, A. R. Lloyd, D. F. Michiel, L. L. Bausserman, D. J. Kelvin, and J. J. Oppenheim. 1994. Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J. Exp. Med. 180: 203-209.
24. Patel, H., R. Fellowes, S. Coade, and P. Woo. 1998. Human serum amyloid A has cytokine-like properties. Scand. J. Immunol. 48: 410-418.
25. He, R., H. Sang, and R. D. Ye. 2003. Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R. Blood 101: 1572-1581.
26. He, R., L. W. Shepard, J. Chen, Z. K. Pan, and R. D. Ye. 2006. Serum amyloid A is an endogenous ligand that differentially induces IL-12 and IL-23. J. Immunol. 177: 4072-4079.
27. He, R. L., J. Zhou, C. Z. Hanson, J. Chen, N. Cheng, and R. D. Ye. 2009. Serum amyloid A induces G-CSF expression and neutrophilia via Toll-like receptor 2. Blood 113: 429-437.
28. Cheng, N., R. He, J. Tian, P. P. Ye, and R. D. Ye. 2008. Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A. J. Immunol. 181: 22-26.
29. Ather, J. L., K. Ckless, R. Martin, K. L. Foley, B. T. Suratt, J. E. Boyson, K. A. Fitzgerald, R. A. Flavell, S. C. Eisenbarth, and M. E. Poynter. 2011. Serum amyloid A activates the NLRP3 inflammasome and promotes Th17 allergic asthma in mice. J. Immunol. 187: 64-73.
30. Vallon, R., F. Freuler, N. Desta-Tsedu, A. Robeva, J. Dawson, P. Wenner, P. Engelhardt, L. Boes, J. Schnyder, C. Tschopp, et al. 2001. Serum amyloid A (apoSAA) expression is up-regulated in rheumatoid arthritis and induces transcription of matrix metalloproteinases. J. Immunol. 166: 2801-2807.
31. Christenson, K., L. Björkman, S. Ahlin, M. Olsson, K. Sjöholm, A. Karlsson, and J. Bylund. 2013. Endogenous acute phase serum amyloid A lacks proinflammatory activity, contrasting the two recombinant variants that activate human neutrophils through different receptors. Front. Immunol. 4: 92.
32. Kim, M. H., M. C. de Beer, J. M. Wroblewski, N. R. Webb, and F. C. de Beer. 2013. SAA does not induce cytokine production in physiological conditions. Cytokine 61: 506-512.
33. Chen, K., Y. Le, Y. Liu, W. Gong, G. Ying, J. Huang, T. Yoshimura, L. Tessarollo, and J. M. Wang. 2010. A critical role for the g protein-coupled receptor mFPR2 in airway inflammation and immune responses. J. Immunol. 184: 3331-3335.
34. Zhang, X., R. Goncalves, and D. M. Mosser. 2008. The isolation and characterization of murine macrophages. Curr. Protoc. Immunol. Chapter 14: Unit 14.1. doi:10.1002/0471142735.im1401s83.
35. Romero, M. J., D. H. Platt, H. E. Tawfik, M. Labazi, A. B. El-Remessy, M. Bartoli, R. B. Caldwell, and R. W. Caldwell. 2008. Diabetes-induced coronary vascular dysfunction involves increased arginase activity. Circ. Res. 102: 95-102.
36. Glogauer, M., C. C. Marchal, F. Zhu, A. Worku, B. E. Clausen, I. Foerster, P. Marks, G. P. Downey, M. Dinauer, and D. J. Kwiatkowski. 2003. Rac1 deletion in mouse neutrophils has selective effects on neutrophil functions. J. Immunol. 170: 5652-5657.
37. Soehnlein, O., and L. Lindbom. 2010. Phagocyte partnership during the onset and resolution of inflammation. Nat. Rev. Immunol. 10: 427-439.
38. Leverrier, Y., and A. J. Ridley. 2001. Requirement for Rho GTPases and PI 3-kinases during apoptotic cell phagocytosis by macrophages. Curr. Biol. 11: 195-199.
39. Kong, L., L. Sun, H. Zhang, Q. Liu, Y. Liu, L. Qin, G. Shi, J. H. Hu, A. Xu, Y. P. Sun, et al. 2009. An essential role for RIG-I in Toll-like receptor-stimulated phagocytosis. Cell Host Microbe 6: 150-161.
40. Satoh, T., O. Takeuchi, A. Vandenbon, K. Yasuda, Y. Tanaka, Y. Kumagai, T. Miyake, K. Matsushita, T. Okazaki, T. Saitoh, et al. 2010. The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat. Immunol. 11: 936-944.
41. Su, S. B., W. Gong, J. L. Gao, W. Shen, P. M. Murphy, J. J. Oppenheim, and J. M. Wang. 1999. A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J. Exp. Med. 189: 395-402.
42. Sandri, S., D. Rodriguez, E. Gomes, H. P. Monteiro, M. Russo, and A. Campa. 2008. Is serum amyloid A an endogenous TLR4 agonist? J. Leukoc. Biol. 83: 1174-1180.
43. Urieli-Shoval, S., R. P. Linke, and Y. Matzner. 2000. Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states. Curr. Opin. Hematol. 7: 64-69.
44. 4 receptor: implications for resolution of inflammation. J. Leukoc. Biol. 84: 600-606.
45. Yan, Q., L. Sun, Z. Zhu, L. Wang, S. Li, and R. D. Ye. 2014. Jmjd3-mediated epigenetic regulation of inflammatory cytokine gene expression in serum amyloid A-stimulated macrophages. Cell. Signal. 26: 1783-1791.
46. Bowdridge, S., and W. C. Gause. 2010. Regulation of alternative macrophage activation by chromatin remodeling. Nat. Immunol. 11: 879-881.
47. De Santo, C., R. Arscott, S. Booth, I. Karydis, M. Jones, R. Asher, M. Salio, M. Middleton, and V. Cerundolo. 2010. Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A. Nat. Immunol. 11: 1039-1046.
48. Negishi, H., Y. Ohba, H. Yanai, A. Takaoka, K. Honma, K. Yui, T. Matsuyama, T. Taniguchi, and K. Honda. 2005. Negative regulation of Toll-like-receptor signaling by IRF-4. Proc. Natl. Acad. Sci. USA 102: 15989-15994.
49. Uhlar, C. M., C. J. Burgess, P. M. Sharp, and A. S. Whitehead. 1994. Evolution of the serum amyloid A (SAA) protein superfamily. Genomics 19: 228-235.
50. Shah, C., R. Hari-Dass, and J. G. Raynes. 2006. Serum amyloid A is an innate immune opsonin for Gram-negative bacteria. Blood 108: 1751-1757.